Novel therapeutic avenues in triple-negative breast cancer: PI3K/AKT inhibition, androgen receptor blockade, and beyond
Multiomic analyses have shed light kenja 88 2023 upon the molecular heterogeneity and complexity of triple-negative breast cancers (TNBCs).With increasing recognition that TNBC is not a single disease entity but encompasses different disease subtypes, a one-size-fits-all treatment paradigm has become obsolete.In this context, the inhibition of phos